Skip to main content

Table 1 Patients’ characteristics

From: Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Characteristics

n (%)

Age, years

 Median

56

 Range

25–90

FIGO stage

 IB1–IIA2

77 (7.7)

 IIB

456 (45.5)

 IIIA

62 (6.2)

 IIIB

393 (39.2)

 IVA

14 (1.4)

Histology

 Squamous carcinoma

970 (96.8)

 Adenocarcinoma

29 (2.9)

 Adenosquamous carcinoma

3 (0.3)

Concurrent chemotherapy

 Yes

708 (70.7)

 No

294 (29.3

Consolidate chemotherapy

 Yes

368 (36.7)

 No

634 (63.3)

Three-dimensional brachytherapy

 Yes

32 (3.2)

 No

Patients with LNs

970 (96.8)

 Yes

580 (57.9)

 No

422 (42.1)

Patients with LNs in different locations

 Pelvic only

491 (49)

 Para-aortic ± pelvic

89 (8.9)

Number of LNs

1310

Number of LNs per patient

 Median

2

 Range

1–16

Short diameter of LNs

 Range, cm

0.4–4.8

  < 1 cm

878 (67)

 1–2 cm

374 (28.5)

  ≥ 2 cm

58 (4.4)

 Range of LNs ≥ 2 cm, cm

2–4.8

 Median of LNs ≥ 2 cm, cm

2.25